Development and validation of an artificial intelligence based screening tool for detection of retinopathy of

Divya Parthasarathy Rao1, Florian M Savoy2, Joshua Zhi En Tan2

  • 1Artificial Intelligence Research and Development, Remidio Innovative Solutions Inc., Glen Allen, VA, United States.

Frontiers in Pediatrics
|October 5, 2023
PubMed

Insights

A new AI algorithm effectively screens for retinopathy of prematurity (ROP) in infants, showing high accuracy. This tool could reduce specialist screening needs, improving efficiency for high-risk preterm infants.

Area of Science:

  • Ophthalmology
  • Artificial Intelligence
  • Medical Imaging

Background:

  • Retinopathy of prematurity (ROP) is a leading cause of childhood blindness.
  • Early detection and treatment are crucial for preventing vision loss in preterm infants.
  • Current screening methods can be resource-intensive and require specialized expertise.

Purpose of the Study:

  • To develop and validate an artificial intelligence (AI) algorithm for screening retinopathy of prematurity (ROP).
  • To assess the algorithm's performance as a diagnostic tool in a real-world setting.

Main Methods:

  • A deep learning (DL) algorithm was developed using 227,326 wide-field retinal images from the KIDROP tele-ROP screening program in India.
  • The dataset, comprising 37,477 temporal retina images, was split into training, validation, and independent test sets.
  • The algorithm functions as a binary classifier to detect ROP (Stages 1-3) versus absence of ROP, with labels derived from expert ROP grader diagnoses.

Main Results:

  • The AI algorithm achieved high sensitivity (91.46%) and specificity (91.22%) in detecting ROP on an independent test set of 7,489 images.
  • The positive predictive value (PPV) was 81.72% and the negative predictive value (NPV) was 96.14%.
  • The area under the receiver operating characteristic curve (AUROC) was 0.970, indicating excellent discriminatory performance.

Conclusions:

  • The developed AI algorithm demonstrates significant potential as a screening tool for retinopathy of prematurity.
  • Its high accuracy suggests it could streamline ROP screening processes.
  • Prospective clinical validation on a tele-ROP platform is planned to further evaluate its real-world utility and workflow efficiency benefits.
Abstract

Related Concept Videos